Centessa Pharmaceuticals
CNTA----
Centessa Pharmaceuticals (CNTA)
Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Centessa Pharmaceuticals Analyst Rating
View MoreForecast & Rating
Jun 10, 2026Price forecast
$44.179.05%
Forecast & RatingBuy
12analysts
- Strong buy25.00%
- Buy8.33%
- Hold66.67%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · Jun 25 at 02:13 AM
BCS Wealth Management Has $1.68 Million Stock Position in Eli Lilly and Company $LLY
- TradingView · Jun 24 at 05:36 PM
Farallon Capital Management Discloses Investment in Centessa with 6.1% Stake
- PUBT · Jun 24 at 08:00 AM
Centessa deal with Lilly closes, shareholders to receive $38 per share plus CVRs
- StockTitan · Jun 23 at 11:45 PM
Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | LLY Stock News
- PUBT · Jun 22 at 03:05 PM
Centessa says UK court approves Lilly acquisition at $38 a share plus CVR
- benzinga_article · Jun 17 at 12:35 PM
7 Health Care Stocks With Whale Alerts In Today's Session
